Konjac Mannan and Ginseng Compositions and Methods and Uses Thereof
Abstract
Described are a number of compositions, namely a konjac mannan mixture, a ginseng composition, and a composition comprising konjac mannan and American ginseng. Methods of use of these compositions are described including their use for reducing blood glucose in non-diabetic and diabetic individuals, as well as reducing postprandial blood glucose in such individuals. Applications in the treatment of hyperlipidemia, high blood pressure, an increase in nitric oxide, Syndrome X and cardiovascular disease are also described. Various other applications of the compositions and methods are also described.
Claims
exact text as granted — not AI-modified1 - 43 . (canceled)
44 . A composition of matter for reducing blood glucose comprising ginseng.
45 . The composition of claim 44 wherein the ginseng is an extract of ginseng.
46 . The composition according to claim 44 wherein the ginseng comprises a ratio of diols/triols of greater than about 1.5.
47 . The composition according to claim 44 wherein the composition is formulated into a liquid, powder or food.
48 . A method for the treatment or prevention of a disorder which benefits from reducing blood glucose in an animal comprising administering to the animal in need thereof a sufficient amount of ginseng.
49 . The method according to claim 48 wherein the ginseng is an extract of ginseng.
50 . The method according to claim 48 wherein the ginseng is administered before a meal or with a meal.
51 . The method according to claim 48 wherein administration before the meal occurs from about 1 to about 180 minutes before the meal.
52 . The method according to claim 48 wherein the amount of ginseng is at least about 1000 mg per administration.
53 . The method according to claim 48 wherein the ginseng comprises a ratio of diols/triols of greater than about 1.5.
54 . The method according to claim 48 wherein the ginseng is administered as a food, a powder, or a liquid.
55 . The method according to claim 48 wherein the ginseng is American ginseng.
56 . The method according to claim 48 wherein the disorder which benefits from reducing blood glucose is diabetes, heart disease, or syndrome X.
57 . The method according to claim 48 wherein the method increases insulin sensitivity in an animal.
58 . The method according to claim 48 wherein the disorder comprises type 2 diabetes.
59 . The method according to claim 48 wherein the method reduces systolic blood pressure, blood cholesterol or lipids.
60 . The method according to claim 48 wherein the method increases insulin secretion.
61 . The method according to claim 48 wherein the animal comprises a human.
62 . A method for the treatment or prevention of a disorder which benefits from reducing blood glucose in an animal comprising administering to the animal a sufficient amount of a composition comprising a konjac mannan mixture and ginseng.Join the waitlist — get patent alerts
Track US2008131531A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.